1-(3-AMINO-4-HYDROXY-PHENYL)-3-CYCLOPROPYL-5-(2-FLUORO-4-IODO-ANILINO)-6,8-DIMETHYL-PYRIDO(4,3-D)PYRIMIDINE-2,4,7-TRIONE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C24H21FIN5O4
Molecular Weight	589.3575
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of 1-(3-AMINO-4-HYDROXY-PHENYL)-3-CYCLOPROPYL-5-(2-FLUORO-4-IODO-ANILINO)-6,8-DIMETHYL-PYRIDO(4,3-D)PYRIMIDINE-2,4,7-TRIONE

Structure Search

SMILES

CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC4=CC=C(I)C=C4F)C5=CC=C(O)C(N)=C5

InChI

InChIKey=KYXOFPAKDRWYQM-UHFFFAOYSA-N

InChI=1S/C24H21FIN5O4/c1-11-20-19(21(29(2)22(11)33)28-17-7-3-12(26)9-15(17)25)23(34)31(13-4-5-13)24(35)30(20)14-6-8-18(32)16(27)10-14/h3,6-10,13,28,32H,4-5,27H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C24H21FIN5O4
Molecular Weight	589.3575
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:18:27 GMT 2025` Edited by `admin` on `Mon Mar 31 23:18:27 GMT 2025`
Record UNII	46E54BA8ND
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

1-(3-AMINO-4-HYDROXY-PHENYL)-3-CYCLOPROPYL-5-(2-FLUORO-4-IODO-ANILINO)-6,8-DIMETHYL-PYRIDO(4,3-D)PYRIMIDINE-2,4,7-TRIONE

Systematic Name

English

GSK-3002415

Preferred Name

English

PYRIDO(4,3-D)PYRIMIDINE-2,4,7(1H,3H,6H)-TRIONE, 1-(3-AMINO-4-HYDROXYPHENYL)-3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-6,8-DIMETHYL-

Systematic Name

English

TRAMETINIB METABOLITE M3

Common Name

English

GSK3002415

Code

English

TRAMETINIB METABOLITE M7

Common Name

English

Code System Code Type Description

PUBCHEM

118796491

Created by admin on Mon Mar 31 23:18:27 GMT 2025 , Edited by admin on Mon Mar 31 23:18:27 GMT 2025

PRIMARY

CAS

1620017-29-9

Created by admin on Mon Mar 31 23:18:27 GMT 2025 , Edited by admin on Mon Mar 31 23:18:27 GMT 2025

PRIMARY

FDA UNII

46E54BA8ND

Created by admin on Mon Mar 31 23:18:27 GMT 2025 , Edited by admin on Mon Mar 31 23:18:27 GMT 2025

PRIMARY

Related Record Type Details


					33E86K87QN

Trametinib

PARENT -> METABOLITE

Comments:

Unit: percent of plasma radioactivity; 48hr; Subject A

Interaction Type:

IN-VIVO

Qualification:

PLASMA

Amount:


					33E86K87QN

Trametinib

PARENT -> METABOLITE

Comments:

Unit: percent of administered dose; 240hr total; Subject A

Interaction Type:

IN-VIVO

Qualification:

URINE

Amount:


					33E86K87QN

Trametinib

PARENT -> METABOLITE

Comments:

Unit: percent of administered dose; Pooled feces (48-240hrs); Subject A

Interaction Type:

IN-VIVO

Qualification:

FECAL

Amount: